<--- Back to Details
First PageDocument Content
Cancer organizations / Breast cancer / Kolling Institute of Medical Research / Cancer research / Institute of Cancer Research / Prostate cancer / Australian Cancer Research Foundation / Breast cancer research stamp / Medicine / Oncology / Ribbon symbolism
Date: 2009-04-30 23:08:58
Cancer organizations
Breast cancer
Kolling Institute of Medical Research
Cancer research
Institute of Cancer Research
Prostate cancer
Australian Cancer Research Foundation
Breast cancer research stamp
Medicine
Oncology
Ribbon symbolism

Microsoft Word - Member_update_070409.doc

Add to Reading List

Source URL: sydney.edu.au

Download Document from Source Website

File Size: 46,12 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

DocID: 1vl9e - View Document